By Yifan Wang Shares of Cansino Biologics rose in Hong Kong, as the regulatory approval for the Chinese biotech firm's vaccine gave investors a boost of.
Vaccitech plc (NASDAQ:VACC – Free Report) Director Joseph Scheeren bought 10,000 shares of Vaccitech stock in a transaction dated Monday, June 26th. The shares were bought at an average cost of $2.44 per share, for a total transaction of $24,400.00. Following the completion of the acquisition, the director now owns 23,000 shares in the company, […]
Vaccitech plc (NASDAQ:VACC – Free Report) Director Joseph Scheeren acquired 10,000 shares of the company’s stock in a transaction dated Monday, June 26th. The shares were bought at an average price of $2.44 per share, for a total transaction of $24,400.00. Following the acquisition, the director now directly owns 23,000 shares of the company’s stock, […]
Vaccitech plc (NASDAQ:VACC – Get Rating) Director Robin Wright bought 13,750 shares of Vaccitech stock in a transaction dated Thursday, May 25th. The stock was purchased at an average price of $2.66 per share, with a total value of $36,575.00. Following the completion of the purchase, the director now owns 48,256 shares in the company, […]